Skip to main content

Novo Nordisk A/S (NYSE: NVO) Investor Securities Class Action Lawsuit 01/24/2025

  • If you purchased a significant amount of shares of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 to December 19, 2024, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2025. NYSE: NVO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 24, 2025 - An investor in shares of Novo Nordisk A/S (NYSE: NVO) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Novo Nordisk A/S in connection with certain allegedly false and misleading statements made between November 2, 2022 to December 19, 2024.   Denmark based Novo Nordisk A/S, together with ...



You must register (for free) or login to view the entire case.